Used in pharmaceutical research as a potent and selective inhibitor of specific kinase enzymes involved in inflammatory and immune-mediated diseases. Shows promise in preclinical studies for treating autoimmune conditions such as rheumatoid arthritis and psoriasis by modulating signaling pathways that drive chronic inflammation. Its structure enables high target affinity and improved metabolic stability, making it a valuable candidate in the development of oral therapeutics. Also investigated for oncology applications due to its ability to interfere with cell proliferation and survival pathways in certain cancer types.